Quality of Life in People With Haemophilia: Results in the Framework of a Nationwide Registry in Colombia.

Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products-Final Results of Athn 2: Factor Switching Study.

The XX Factor in Hemophilia: Diagnostic, Therapeutic, and Research Gaps for Women and Girls.

Patient-Reported Outcome Measures and Clinical Performance in Hemophilia: Implications for Person-Centered Care.

Why "Treat First" Stalls: Knowledge, Scope, and System Determinants of Delayed Haemostatic Therapy in the Emergency Department.

The Analysis of the FIX-inhibitor Risks Associated With the F9 Genotype in Patients With Haemophilia B Exposes the Involvement of Nonsense Mediated-decay: Argentinean and International Series.

Quality of Life in People With Haemophilia: Results in the Framework of a Nationwide Registry in Colombia.

Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products-Final Results of Athn 2: Factor Switching Study.

The XX Factor in Hemophilia: Diagnostic, Therapeutic, and Research Gaps for Women and Girls.

Patient-Reported Outcome Measures and Clinical Performance in Hemophilia: Implications for Person-Centered Care.

Why "Treat First" Stalls: Knowledge, Scope, and System Determinants of Delayed Haemostatic Therapy in the Emergency Department.

The Analysis of the FIX-inhibitor Risks Associated With the F9 Genotype in Patients With Haemophilia B Exposes the Involvement of Nonsense Mediated-decay: Argentinean and International Series.